Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron for hypotension in rheumatic C-section
NCT05314257Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of granisetron in hypotension, bradycardia, sponsored by Assiut University. Status: unknown.
02
Drugs
granisetron
03
Conditions
hypotensionbradycardia
Beyond the preview
Go deeper on NCT05314257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314257.